Uniklinik Koln
Cologne 50937
4 studies enrolling now · 12 studies all time
What they study most
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Ewing's Osteosarcoma, Fibrodysplasia Ossificans Progressiva (FOP), Geographic Atrophy Secondary to Age-related Macular Degeneration, Glioblastoma Multiforme, Hypochondroplasia, Merkel Cell Carcinoma, Neoplasm Metastasis, Oral Mucositis, Peripheral T-cell Lymphoma, Prostate Cancer
Studies at this site
- A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia — Recruiting now
- To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva — Recruiting now
- A Study of Obexelimab in Patients With Systemic Lupus Erythematosus — Recruiting now
- A Multicenter Multinational Observational Study of Children With Hypochondroplasia — Recruiting now
- An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
- Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia — Running, not enrolling
- CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) — Running, not enrolling
- Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia — Enrolling by invitation
- Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma — Status unconfirmed
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. — Completed
- Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects — Stopped early
- A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma — Completed